A recent study from Butler/Till Health, which surveyed more than 200 U.S.-based healthcare providers – including gastroenterologists, hematologists, neurologists, and dermatologists – reveals that providers are largely on the fence about the effectiveness of virtual events, yet predict increased attendance as the economy restarts in such events after COVID-19. 

The large majority of patient respondents to a survey by Doctor.com (83 percent) say they will likely use telemedicine even after the Covid-19 pandemic ends. 55 percent of patients are willing to use telemedicine to see new doctors, and 69 percent convey that “easy-to-use technology” would help them decide to make a telemedicine appointment.

Public safety is the world’s singular goal as mandatory quarantines, shelter-in-place orders, travel restrictions, and mandatory work-from-home policies go into effect to curb the spread of COVID-19. In response, many biopharmaceutical companies are shifting how they work: Amarin withdrew part of its field force, while Amgen and Merck have instructed their sales teams to halt all in-person meetings with physicians and hospitals.

According to a study released by Infogroup, a provider of data and data-driven intelligence solutions, four in five consumers say they are more concerned about privacy than they used to be – a tendency marketers ought to keep in mind.

The data changing hands in the new data-driven healthcare partnership between Google and St. Louis-based health system Ascension runs the gamut from patient names and birth dates to lab results and previous hospitalizations.

Over the last 15 years healthcare professionals and patients have rapidly adopted digital and social channels. Like most of society, they expect to be able to find the information they need, in a format they want, and in the channels they prefer. They will not tolerate poor customer experiences, as there are always alternatives available to them.

In the second of a two-part series on improving content management, Veeva Systems discusses how Merck implemented a modular content strategy and is now seeing significant improvements in process efficiency, time to market, customer engagement, and digital transformation.

Researchers at Children’s Hospital of Philadelphia (CHOP) confirmed the acceptability, feasibility, and safety of a digital medicine tool designed as an investigational treatment for children with autism spectrum disorder and co-occurring attention/deficit-hyperactivity disorder.

In the first of a two-part series, Veeva Systems discusses two strategies to speed development of commercial content and improve compliance in life sciences. Read how Shire increased its efficiency and effectiveness with digital asset management. In the June 2019 edition of Med Ad News, learn how Merck built off of its digital asset management foundation to implement a successful modular content strategy.

Novartis launched its Galaxies of Hope app, a unique digital experience created to support the neuroendocrine tumor community.